Orchard Therapeutics' Series A Round

Orchard Therapeutics raised a round of funding on May 03, 2016.

Orchard Therapeutics is a biotechnology company focused on the development and commercialization of transformative ex-vivo gene therapies for patients with orphan diseases. Orchard's development progr…

Articles about Orchard Therapeutics' Series A Round: